Literature DB >> 22559165

Fractionation of whey protein isolate with supercritical carbon dioxide to produce enriched α-lactalbumin and β-lactoglobulin food ingredients.

Laetitia M Bonnaillie1, Peggy M Tomasula.   

Abstract

An environmentally friendly protein fractionation process using supercritical carbon dioxide (SCO(2)) as an acid was developed to produce enriched α-lactalbumin (α-LA) and β-lactoglobulin (β-LG) fractions from whey protein isolate solutions containing from 2 to 10% WPI. This study investigated the effects of pH, temperature, WPI concentration, and residence time on the precipitation kinetics and recovery yields of individual whey proteins and the relative enrichment and composition of both protein fractions. At 5.5-34 MPa and 60-65 °C, solubilized SCO(2) decreased solution pH and induced the formation and precipitation of α-LA aggregates. Gel electrophoresis and HPLC of the enriched fractions demonstrated the production of ≥ 60% pure α-LA, and ≥ 70% pure β-LG, under various operating conditions, from WPI containing ∼57% β-LG and 21% α-LA. The enriched fractions are ready-to-use food ingredients with neutral pH, untainted by acids and contaminants.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22559165     DOI: 10.1021/jf3011036

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  3 in total

Review 1.  Emerging trends in nutraceutical applications of whey protein and its derivatives.

Authors:  Seema Patel
Journal:  J Food Sci Technol       Date:  2015-06-09       Impact factor: 2.701

2.  Enrichment and Purification of Casein Glycomacropeptide from Whey Protein Isolate Using Supercritical Carbon Dioxide Processing and Membrane Ultrafiltration.

Authors:  Laetitia M Bonnaillie; Phoebe Qi; Edward Wickham; Peggy M Tomasula
Journal:  Foods       Date:  2014-01-09

Review 3.  Protein Recovery from Underutilised Marine Bioresources for Product Development with Nutraceutical and Pharmaceutical Bioactivities.

Authors:  Trung T Nguyen; Kirsten Heimann; Wei Zhang
Journal:  Mar Drugs       Date:  2020-07-27       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.